Mrs. Elizabeth C Prudenti, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1515 Us Highway 1, Suite 201, Sebastian, FL 32958 Phone: 772-589-7680 Fax: 772-589-9294 |
Jennifer Weber, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1573 Picasso St, Sebastian, FL 32958 Phone: 772-584-0672 |
Ms. Gayle L. Clelland, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 620 Helicon Ter, Sebastian, FL 32958 Phone: 772-643-2838 |
Ms. Ganga Mayee Joyce Wasserman, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 7766 Bay St, #11, Sebastian, FL 32958 Phone: 772-589-7008 Fax: 772-589-7008 |
Ms. Rachel Dawn Williams, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1533 Dewitt Ln, Sebastian, FL 32958 Phone: 305-240-0151 |
James William Ranahan, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 13225 Us Highway 1, A12, Sebastian, FL 32958 Phone: 772-766-9152 |
Dana Failla Langan Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 826 Lorca Ave, Sebastian, FL 32958 Phone: 772-532-4950 |
News Archive
Pulse Health announces Revelar the first non-invasive device to help healthcare professionals and their patients measure aldehydes and help minimize free radical damage. Revelar is breakthrough breath technology that accurately detects and measures the presence of aldehydes, which are indicators of free radical damage in the body.
In GlobalPost's "Global Pulse" blog, Mia Mazer, a media and communications intern with the International Planned Parenthood Federation/Western Hemisphere Region, writes about the formation of the Mesoamerican Coalition for Comprehensive Sexuality Education, a regional advocacy initiative of more than 40 different organizations that aims to hold governments accountable to a 2008 Ministerial Declaration, titled "Preventing through Education."
SCIENTISTS have unearthed crucial new genetic information about how breast cancer develops and the genetic changes which can be linked to survival, according to a Cancer Research UK-funded study published in Nature Communications today (Tuesday).
A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
› Verified 2 days ago